Aspira Women’s Health Inc. (NASDAQ:AWH) Shares Bought by B. Riley Wealth Advisors Inc.

B. Riley Wealth Advisors Inc. grew its position in Aspira Women’s Health Inc. (NASDAQ:AWH) by 33.8% in the third quarter, HoldingsChannel reports. The fund owned 316,294 shares of the company’s stock after acquiring an additional 79,898 shares during the quarter. B. Riley Wealth Advisors Inc.’s holdings in Aspira Women’s Health were worth $256,000 at the end of the most recent reporting period.

Separately, Pine Valley Investments Ltd Liability Co purchased a new position in shares of Aspira Women’s Health in the 3rd quarter valued at about $25,000. Institutional investors own 12.19% of the company’s stock.

Aspira Women’s Health Stock Performance

Aspira Women’s Health stock opened at $0.77 on Friday. The stock has a market capitalization of $12.83 million, a P/E ratio of -0.64 and a beta of 1.39. The company’s fifty day moving average price is $0.82 and its 200 day moving average price is $1.08. Aspira Women’s Health Inc. has a 1 year low of $0.67 and a 1 year high of $5.65.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on Aspira Women’s Health in a report on Thursday. They issued a “hold” rating for the company.

Aspira Women’s Health Profile

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.